Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-04 Sale | 2026-09-09 7:24 pm | Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner | 259,837 | $7.3345 | $1,905,768 | 3,885,115 (Indirect) | View |
| 2026-09-04 Sale | 2026-09-09 7:23 pm | Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner | 259,837 | $7.3345 | $1,905,768 | 3,885,115 (Indirect) | View |
| 2026-09-01 Sale | 2026-09-03 7:21 pm | Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner | 86,482 | $7.1388 | $617,379 | 4,144,952 (Indirect) | View |
| 2026-09-01 Sale | 2026-09-03 7:21 pm | Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner | 86,482 | $7.1388 | $617,379 | 4,144,952 (Indirect) | View |
| 2026-08-27 Sale | 2026-08-31 6:26 pm | Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner | 86,914 | $7.0849 | $615,777 | 4,231,434 (Indirect) | View |
| 2026-08-27 Sale | 2026-08-31 6:25 pm | Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner | 86,914 | $7.0849 | $615,777 | 4,231,434 (Indirect) | View |
| 2026-08-24 Sale | 2026-08-26 9:28 pm | Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner | 62,714 | $7.3595 | $461,546 | 4,318,348 (Indirect) | View |
| 2026-08-24 Sale | 2026-08-26 9:27 pm | Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner | 62,714 | $7.3595 | $461,546 | 4,318,348 (Indirect) | View |
| 2026-08-06 Sale | 2026-08-10 7:54 pm | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director | 155,255 | $6.9495 | $1,078,937 | 3,784,650 (Indirect) | View |
| 2026-08-06 Sale | 2026-08-10 7:52 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 62,811 | $6.8751 | $431,829 | 3,877,094 (Indirect Direct) | View |
| 2026-07-30 Sale | 2026-08-03 5:32 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 116,474 | $6.9288 | $807,027 | 3,939,905 (Indirect Direct) | View |
| 2026-07-30 Sale | 2026-08-03 5:26 pm | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 116,474 | $6.9288 | $807,027 | 3,939,905 (Indirect) | View |
| 2026-05-20 Purchase | 2026-05-21 4:31 pm | Entrada Therapeutics Inc. | TRDA | Zeiher Bernhardt G Director | 5,000 | $5.8632 | $29,316 | 5,000 (Indirect) | View |
| 2026-05-04 Sale | 2026-05-04 7:25 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 25,907 | $15.39 | $398,810 | 216,317 (Direct) | View |
| 2026-05-04 Sale | 2026-05-04 7:24 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 15,000 | $15.33 | $229,953 | 248,419 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 4:39 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 2,500 | $12.95 | $32,375 | 119,010 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:35 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 15,010 | $13.04 | $195,771 | 198,588 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 16,477 | $13.01 | $214,379 | 121,510 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 7,988 | $12.25 | $97,892 | 137,987 (Direct) | View |
| 2025-11-21 Sale | 2025-11-24 4:30 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,910 | $9.9811 | $88,932 | 110,026 (Direct) | View |
| 2025-11-20 Purchase | 2025-11-24 4:09 pm | Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner | 28,867 | $9.0708 | $261,846 | 4,691,392 (Indirect) | View |
| 2025-11-14 Sale | 2025-11-18 4:36 pm | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 200,000 | $8.8 | $1,760,000 | 4,056,379 (Indirect) | View |
| 2025-11-14 Sale | 2025-11-18 4:34 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 200,000 | $8.8 | $1,760,000 | 4,056,379 (Indirect Direct) | View |
| 2025-11-10 Purchase | 2025-11-12 5:34 pm | Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner | 178,044 | $7.5969 | $1,352,587 | 4,664,924 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-02 Tax Withholding | 2026-09-03 5:19 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 8,724 | $7.1439 | 517,290 (Direct) | View |
| 2026-09-02 Tax Withholding | 2026-09-03 5:18 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 2,528 | $7.1439 | 196,060 (Direct) | View |
| 2026-09-02 Tax Withholding | 2026-09-03 5:16 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 2,079 | $7.1439 | 214,238 (Direct) | View |
| 2026-09-02 Tax Withholding | 2026-09-03 5:15 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,733 | $7.1439 | 117,277 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 5:34 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 5:17 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 5:16 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | Chapman Gina Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 5:05 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | Radhakrishnan Maha Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 5:01 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | Thistle Mary Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 4:52 pm | N/A 2036-06-10 | Entrada Therapeutics Inc. | TRDA | Zeiher Bernhardt G Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-04 7:24 pm | N/A 2029-12-10 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 15,000 | $0 | 248,419 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-04 7:24 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 15,000 | $1.74 | 248,419 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:21 pm | N/A 2036-03-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 347,400 | $0 | 734,014 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:21 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 9,869 | $11.66 | 734,014 (Direct) | View |
| 2026-03-03 Tax Withholding | 2026-03-03 6:21 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 19,181 | $11.76 | 734,014 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:20 pm | N/A 2036-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 111,200 | $0 | 212,575 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:20 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 2,939 | $11.66 | 212,575 (Direct) | View |
| 2026-03-03 Tax Withholding | 2026-03-03 6:20 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,712 | $11.76 | 212,575 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:19 pm | N/A 2036-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 139,000 | $0 | 296,798 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:19 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 7,223 | $11.66 | 296,798 (Direct) | View |
| 2026-03-03 Tax Withholding | 2026-03-03 6:19 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 14,038 | $11.76 | 296,798 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:18 pm | N/A 2036-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 139,000 | $0 | 325,424 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:18 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 3,898 | $11.66 | 325,424 (Direct) | View |
| 2026-03-03 Tax Withholding | 2026-03-03 6:18 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 7,577 | $11.76 | 325,424 (Direct) | View |
| 2025-09-02 Tax Withholding | 2025-09-04 5:04 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 8,723 | $5.4302 | 415,664 (Direct) | View |
| 2025-09-02 Tax Withholding | 2025-09-04 5:03 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,746 | $5.4302 | 179,059 (Direct) | View |